Clinical Trial Comparing Devices Used for Cardioversion of Atrial Fibrillation
Completed · Not applicable
Conditions studied: Atrial Fibrillation
In brief
The goal of this single center, investigator initiated, open label prospective randomized controlled trial is to compare the efficacy of a single 200J RBW shock and a single 360J BTE shock. The secondary objective of the study is to compare the frequency of adverse events after one or two 200J RBW or 360J BTE shocks
Key facts
- Study ID
- NCT05992623
- Run by
- Inova Health Care Services
- People needed
- 546
- Starts
- 2023-07-21
- Expected to finish
- 2024-12-11
- Last updated by the study team
- 2025-09-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years
- In AF on presentation with plan for DCCV in either the Electrophysiology lab or DCCV procedure area
You may not qualify if…
- Participants who are receiving any other investigational agents.
- Parents/guardians or participants who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.
- Patients with arrhythmias other than AF
- Patients with hemodynamically unstable AF
- Patients with untreated hyperthyroidism
- Patients with known or suspected pregnancy
- Patients without sufficient anticoagulation or a transesophageal echocardiogram or computed tomography scan documenting the absence of intracardiac thrombi
Where it is running
- Inova Health System — Falls Church, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.